Enanta Pharmaceuticals Net Tangible Assets

Enanta Pharmaceuticals (ENTA) currently reports a net tangible assets of $100M as of June 2026. That compares with $79M in the prior-year period — up 27.5% year over year. Use the charts on this page to explore Enanta Pharmaceuticals's net tangible assets history and peer comparisons.

Enanta Pharmaceuticals's net tangible assets increased from $79M to $100M — a 27.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enanta Pharmaceuticals reported $100M in net tangible assets as of June 2026. That compares with $79M in the prior-year period — up 27.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enanta Pharmaceuticals, and consider following ENTA for alerts when major investors trade the stock.

Enanta Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTA with unrelated industries.